安信龙保险 AIZ 深 沪
已收盘 12-19 16:00:00 美东时间
239.02
+0.990
+0.42%
华盛通- 最 高240.09
- 今 开237.72
- 成交量 59.67万股
- 最 低 237.72
- 昨 收 238.03
- 总市值 119.70亿
- 52周最高 240.58
- 市盈率 静 16.53
- 换手率 1.19%
- 52周最低 172.4938
- 委 比 -90.48%
- 总股本 5008.11万
- 历史最高 240.58
- 量 比 1.47
- 振 幅 1.00%
- 历史最低 2.09
- 每 手 1
- 风险率 12.29%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Piper Sandler Maintains Overweight on Assurant, Raises Price Target to $264
Piper Sandler analyst John Barnidge maintains Assurant (NYSE:AIZ) with a Overweight and raises the price target from $252 to $264.
12-19 20:50
美股大行评级 | 最高352美元！14家机构连夜上调英伟达目标价；劳氏、塔吉特、Wix.com等遭多家机构下调目标价
今日重点评级关注：Ascendiant Capital：维持Aclarion"买入"评级，目标价从22美元升至23美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从24美元升至26美元
11-21 15:50
P/E Ratio Insights for Assurant
Looking into the current session, Assurant Inc. (NYSE:AIZ) shares are trading a...
11-21 02:00
Keefe, Bruyette & Woods Maintains Outperform on Assurant, Raises Price Target to $254
Keefe, Bruyette & Woods analyst Tommy McJoynt maintains Assurant (NYSE:AIZ) with a Outperform and raises the price target from $248 to $254.
11-21 01:51
美股大行评级 | Stifel上调特斯拉目标价升至508美元；多家大行上调Vita Coco目标价最高至58美元
今日重点评级关注：HC Wainwright & Co.：维持Oncolytics Biotech"买入"评级，目标价从5美元升至10美元；HC Wainwright & Co.：维持Barinthus Biotherapeutics"买入"评级，目标价从3美元升至4美元
11-18 15:28
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
11-11 10:49
UBS Maintains Buy on Assurant, Raises Price Target to $257
UBS analyst John Nadel maintains Assurant (NYSE:AIZ) with a Buy and raises the price target from $255 to $257.
11-11 03:38
Assurant shares are trading higher after the company reported better-than-expected Q3 financial results.
Assurant shares are trading higher after the company reported better-than-expec...
11-05 05:37
Assurant Q3 Adj. EPS $5.73 Beats $4.28 Estimate, Sales $3.232B Beat $3.188B Estimate
Assurant (NYSE:AIZ) reported quarterly earnings of $5.73 per share which beat the analyst consensus estimate of $4.28 by 34 percent. This is a 91 percent increase over earnings of $3.00 per share from the same period
11-05 05:33
Earnings Scheduled For November 4, 2025
Companies Reporting Before The Bell • Sequans Communications (NYSE:SQNS) is lik...
11-04 19:12
